发明名称 Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides
摘要 Disclosed are processes for preparing [(3-hydroxypyridine-2-carbonyl)amino]-alkanoic acids, derivatives, inter alia, 5-aryl substituted and 5-heteroaryl substituted [(3-hydroxypyridine-2-carbonyl]amino}acetic acids. Further disclosed are methods for making prodrugs of [(3-hydroxypyridine-2-carbonyl)-amino]acetic acids, for example, [(3-hydroxypyridine-2-carbonyl]amino}acetic acid esters and {[3-hydroxypyridine-2-carbonyl]amino}acetic acid amides. The disclosed compounds are useful as prolyl hydroxylase inhibitors or for treating conditions wherein prolyl hydroxylase inhibition is desired.
申请公布号 US9145366(B2) 申请公布日期 2015.09.29
申请号 US201213488554 申请日期 2012.06.05
申请人 Akebia Therapeutics, Inc. 发明人 Lanthier Christopher M.;Gorin Boris;Oudenes Jan;Dixon Craig Edward;Lu Alan Qingbo;Copp James Densmore;Janusz John Michael
分类号 C07D211/72;C07D211/84;C07D213/62;C07D213/78;C07D213/79;C07D213/81;C07D213/803 主分类号 C07D211/72
代理机构 Jones Day 代理人 Jones Day
主权项 1. A process for preparing a compound having the formula: wherein R1 is chosen from: L is a linking unit having the formula: —(CR7aR7b)n—R7a and R7b are each independently:i) hydrogen; orii) C1-C6 linear, C3-C6 branched or C3-C6 cyclic alkyl;R8 is chosen from hydrogen, methyl, or ethyl; andthe index n is an integer from 1 to 4;or a pharmaceutically acceptable salt thereof,comprising:A) reacting a boronic acid with a 3,5-dihalo-2-cyanopyridine having the formula: each Z is independently chloro or bromo, in the presence of a catalyst, to form a 5-aryl or 5-heteroaryl-3-halo-2-cyanopyridine having the formula: B) reacting the 5-aryl or 5-heteroaryl-3-halo-2-cyanopyridine formed in step (A) with an alkoxide anion having the formula: ⊖OR2 wherein R2 is C1-C12 linear alkyl or C3-C12 branched alkyl, to form a 5-aryl or 5-heteroaryl-3-alkoxy-2-cyanopyridine having the formula: C) reacting the 5-aryl or 5-heteroaryl-3-alkoxy-2-cyanopyridine formed in step (B) with an acid to form a 5-aryl or 5-heteroaryl-3-hydroxy-2-carboxypyridine having the formula:and D) reacting the 5-aryl or 5-heteroaryl-3-hydroxy-2-carboxypyridine formed in step (C) with an amino acid having the formula: wherein the boronic acid is chosen from 2-fluorophenylboronic acid, 3-fluorophenylboronic acid, 4-fluorophenylboronic acid, 2-chlorophenylboronic acid, 3-chlorophenylboronic acid, 4-chlorophenylboronic acid, 2-methylphenylboronic acid, 3-methylphenylboronic acid, 4-methylphenylboronic acid, 2-methoxyphenylboronic acid, 3-methoxyphenyl-boronic acid, 4-methoxyphenylboronic acid, 2-cyanophenylboronic acid, 3-cyano-phenylboronic acid, 4-cyanophenylboronic acid, 2-nitrophenylboronic acid, 3-nitrophenylboronic acid, 4-nitrophenylboronic acid, 2-trifluoromethylphenylboronic acid, 3-trifluoromethylphenylboronic acid, 4-trifluoromethylphenylboronic acid, 2-carbamoylphenylboronic acid, 3-carbamoylphenylboronic acid, 4-carbamoylphenyl-boronic acid, 2-(pyrrolidine-1-carbonyl)phenylboronic acid, 3-(pyrrolidine-1-carbonyl)phenylboronic acid, 4-(pyrrolidine-1-carbonyl)phenylboronic acid, 2-(cyclopropanecarbonylamino)phenylboronic acid, 3-(cyclopropanecarbonyl-amino)phenylboronic acid, 4-(cyclopropanecarbonylamino)phenylboronic acid, 3-chloro-6-methylphenylboronic acid, and 2-chloro-5-methylphenylboronic acid.
地址 Cambridge MA US